S, A. ., Rao, V. M. ., & P. R, S. (2025). A Prospective Cross-sectional study to evaluate the utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic dysfunction associated fatty liver disease (MAFLD) patients in a tertiary care center. Journal of Neonatal Surgery, 14(21S), 848–854. Retrieved from https://jneonatalsurg.com/index.php/jns/article/view/5388